Mergers, acquisitions, strategic partnerships, and product licensing. Plus, strategies and tactics for better deal-making
|
April 1, 2013
By:
William Looney
Pharm Exec's annual look at the trends and best practices in biopharm licensing and M&A for the year ahead.
|
March 1, 2013
By:
Mary Henninger, Mark Feldstein
As small biotech firms test the water in partnerships with Big Pharma, the best calling card is a well-framed strategy on intellectual property.
|
|
December 1, 2012
Eli Lilly's pioneering pact with leading CRO Covance made big news when it happened. Four years later, both parties can point to metrics that suggest the benefit is mutual.
|
|
June 1, 2012
By:
William Looney
Pharm Exec convened a panel of heavy hitters in business development to crack the bat on best practices in licensing and M&A for the year ahead.
|
|
December 1, 2011
By:
Ben Comer
It's a neck and neck race toward safer, faster, and medically superior treatments. Which organizations have what it takes to jockey their products into the winner's circle?
|
October 1, 2011
Top 10 Companies by Market Share
|
October 1, 2011
Top 10 Products Worldwide
|
October 1, 2011
30 Years of Pharma: Perspective in Numbers
|
|
September 1, 2011
By:
Bill Trombetta
Bill Trombetta surveys the landscape of pharma financials over the past year, and shows which companies rode the wave to the top of the industry in delivering value to shareholders.
|
|
PharmExec Blog
Follow Us
RSS
Bookstore
